individual investors
institutions & advisors
My Value Line
Sign In
Subscribe
Value Line
smaller
default
larger
Research Hub
Stocks
Overview
Dow 30 Coverage
Investment Survey
Investment Survey Plus
Small & Midcap Survey
Special Situations
Select
Dividend Select
Value Line 600
Analyzer
Funds
Overview
Fund Advisor
Fund Advisor Plus
Fund Survey for Windows
Options
Overview
Options Survey
Convertibles
Overview
Convertibles Survey
ETF
ETF Professional
Tools
Overview
Screener
Model Portfolio
Portfolio Tracker
Glossary
Markets
Overview
Daily Updates
Economic Calendar
Commentary
Products
Overview
Stocks
Funds
Options
Convertibles
ETFs
Data Licensing
Research Center
Investment Education
Overview
Getting Started
How To Use
Sample Reports
Guides
Articles
FAQs
Glossary
Free Reports
Ranks
Research
My Value Line
Market Review
Symbol Lookup
Products
Research Center
Investment Survey
Investment Survey Plus
Value Line 600
Small & Midcap Survey
Select
Dividend Select
Special Situations
Analyzer
Fund Advisor
Fund Advisor Plus
Fund Survey for Windows
Options Survey
Convertibles Survey
ETF Professional
Free Reports
Need help?
View Our FAQs
Retrieve Password
Contact Us
View Our Guides
Glossary
Quote Lookup
Please enter a ticker symbol below and click Submit.
Symbol:
VL Survey Page
(2013-03-15)
Quotes
News
Option Data
Graphs
Time/Sales
Regeneron Pharmaceuticals Inc (REGN)
2013-05-22@11:55:53 ET
Regeneron Pharmaceuticals Bullish Moving Average Crossover Alert (REGN) (F78)
2013-05-22@05:28:45 ET
Form 144: Filing to Sell 23038 Shares of Regeneron Pharmaceuticals In (REGN) (VKR)
2013-05-22@05:01:09 ET
Form 144: Filing to Sell 5529 Shares of Regeneron Pharmaceuticals In (REGN) (VKR)
2013-05-21@17:09:19 ET
Watch for Regeneron Pharmaceuticals to Potentially Rebound After Falling 1.40% Yesterday (PSM)
2013-05-21@11:14:07 ET
Stock Investors Sell Off Shares of Regeneron Pharmaceuticals, Down 1.5% (F77)
2013-05-21@10:36:33 ET
Regeneron Pharmaceuticals Shares Up 53.7% Since SmarTrend's Buy Recommendation (REGN) (PSM)
2013-05-21@08:15:00 ET
Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine (PRN)
2013-05-21@05:48:57 ET
Form 144: Filing to Sell 5000 Shares of Regeneron Pharmaceuticals In (REGN) (VKR)
2013-05-21@03:22:18 ET
8-K: REGENERON PHARMACEUTICALS INC (EDK)
2013-05-20@12:22:13 ET
Earnings Look Back: Regeneron Pharmaceuticals Is Up 0.3% Since Reporting Quarterly Results 2 Weeks Ago (REGN) (PSM)
2013-05-18@11:30:33 ET
Form 4: Update Filing for Regeneron Pharmaceuticals Inc (REGN) (VKR)
2013-05-18@11:30:23 ET
Form 4: Update Filing for Regeneron Pharmaceuticals Inc (REGN) (VKR)
2013-05-18@09:56:12 ET
Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Regeneron Pharmaceuticals Is Up 0.3% (REGN) (F73)
2013-05-17@03:29:57 ET
Australia Patent: Regeneron Pharmaceuticals Files Application for 'Restricted immunoglobulin heavy chain mice' (ABW)